Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Select Fund” fourth-quarter 2025 investor letter. It is a non-diversified fund that focuses on long-term capital appreciation ...
Sanofi is boosting its vaccine portfolio and pipeline through the acquisition of Dynavax Technologies, a $2.2 billion deal bringing assets that could give the company competitive advantages over ...
EMERYVILLE, Calif., Dec. 24, 2025 /PRNewswire/ -- Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation, a publicly traded vaccines company with a ...
Sanofi ( (SNY)) just unveiled an update. In November 2025, Sanofi announced significant advancements in its pharmaceutical offerings. On November 7, 2025, Sanofi, in collaboration with Regeneron, ...
Adjusted Total Revenue is a non-GAAP financial measure. Adjusted Total Revenue is total revenue excluding Sanofi Supply Sales, Sanofi Royalties and Sanofi Influenza-COVID-19 Combination and Matrix-M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results